Aditxt Inc (ADTX)
2.39
-0.14
(-5.53%)
USD |
NASDAQ |
Apr 26, 16:00
2.43
+0.04
(+1.67%)
After-Hours: 20:00
Aditxt Free Cash Flow (Quarterly): -3.309M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.309M |
| September 30, 2023 | -8.043M |
| June 30, 2023 | -3.282M |
| March 31, 2023 | -3.957M |
| December 31, 2022 | -6.809M |
| September 30, 2022 | -7.823M |
| June 30, 2022 | -2.781M |
| March 31, 2022 | -5.347M |
| December 31, 2021 | -8.806M |
| September 30, 2021 | -4.708M |
| Date | Value |
|---|---|
| June 30, 2021 | -5.239M |
| March 31, 2021 | -4.540M |
| December 31, 2020 | -3.156M |
| September 30, 2020 | -3.830M |
| June 30, 2020 | -0.1547M |
| March 31, 2020 | -0.2509M |
| December 31, 2019 | -0.0489M |
| September 30, 2019 | -0.1062M |
| June 30, 2019 | -0.0732M |
| March 31, 2019 | -0.236M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-8.806M
Minimum
Dec 2021
-0.0489M
Maximum
Dec 2019
-3.803M
Average
-3.830M
Median
Sep 2020
Free Cash Flow (Quarterly) Benchmarks
| Evofem Biosciences Inc | -0.17M |
| Perspective Therapeutics Inc | -9.097M |
| Electromed Inc | 3.384M |
| Xtant Medical Holdings Inc | -1.278M |
| Asensus Surgical Inc | -13.45M |